N@N

Christopher Rolland Maintained (TXN) at Buy and Held Target at $215 on, May 31st, 2022

Christopher Rolland of Susquehanna, Maintained "Texas Instruments Incorporated" (TXN) at Buy and Held Target at $215 on, May 31st, 2022.

Christopher has made no other calls on TXN in the last 4 months.

There are 14 other peers that have a rating on TXN. Out of the 14 peers that are also analyzing TXN, 7 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Timothy Arcuri of "UBS" Maintained at Hold with Decreased Target to $175 on, Wednesday, April 27th, 2022
• Tore Svanberg of "Stifel" Maintained at Hold with Decreased Target to $170 on, Wednesday, April 27th, 2022
• Vijay Rakesh of "Mizuho" Maintained at Hold with Decreased Target to $175 on, Wednesday, April 27th, 2022
• William Stein of "Truist Securities" Maintained at Hold with Decreased Target to $172 on, Wednesday, April 27th, 2022
• Christopher Caso of "Raymond James" Downgraded from Buy to Hold on, Monday, February 14th, 2022
• Logan Purk of "Edward Jones" Downgraded from Strong Buy to Hold on, Friday, February 11th, 2022
• Ross Seymore of "Deutsche Bank" Maintained at Hold with Decreased Target to $175 on, Friday, February 4th, 2022

These are the ratings of the 7 analyists that currently disagree with Christopher

---

• Blayne Curtis of "Barclays" Maintained at Sell with Decreased Target to $150 on, Wednesday, April 27th, 2022
• John Vinh of "Keybanc" Maintained at Buy with Decreased Target to $220 on, Wednesday, April 27th, 2022
• Joseph Moore of "Morgan Stanley" Maintained at Sell with Decreased Target to $170 on, Wednesday, April 27th, 2022
• Vivek Arya of "B of A Securities" Maintained at Strong Buy with Decreased Target to $190 on, Wednesday, April 27th, 2022
• Mark Lipacis of "Jefferies" Maintained at Strong Buy and Held Target at $203 on, Wednesday, April 27th, 2022
• Randy Abrams of "Credit Suisse" Maintained at Buy with Decreased Target to $195 on, Wednesday, April 27th, 2022
• Ambrish Srivastava of "BMO Capital" Maintained at Buy and Held Target at $215 on, Tuesday, April 26th, 2022

Contributing Sources

---